These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1571341)

  • 1. Initial success of steroid weaning late after heart transplantation.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Moriguchi JD; Kawata N; Fandrich R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1992; 11(2 Pt 2):428-30. PubMed ID: 1571341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
    J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
    J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
    J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
    J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Gleeson MP; Moriguchi JD; Kawata N; Minkley R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1995; 14(5):963-7. PubMed ID: 8800734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of steroid tapering after steroid pulse therapy for heart rejection.
    Lonquist JL; Radovancevic B; Vega JD; Burnett CM; Birovljev S; Saade NG; Duncan JM; Frazier OH
    J Heart Lung Transplant; 1992; 11(5):913-9. PubMed ID: 1420239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKT3 treatment of cardiac allograft rejection.
    Haverty TP; Sanders M; Sheahan M
    J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it possible to reduce the number of endomyocardial biopsies with new immunosuppressive drugs?
    Lage E; Ballesteros S; Mogollón MV; Ordóñez A; Gómez S; Hernández A; Hinojosa R
    Transplant Proc; 2006 Oct; 38(8):2544-6. PubMed ID: 17097996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.